Catalyst Wire Dossier Catalyst Wire Dossier

OPVEE

Nalmefene hydrochloride · Indivior Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPVEE, covering 2023-05-22 to 2023-05-22. Get the full timeline:

Most recent: FDA Approved: OPVEE — Original Application (Indivior Inc.)

See pricing